Antiviral Approaches against Influenza Virus-Reference-Cited by-同舟云学术

Antiviral Approaches against Influenza Virus

Published:2023-03-23 Issue:1 Volume:36 Page:
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Kumari Rashmi¹²,Sharma Suresh D.¹,Kumar Amrita¹,Ende Zachary¹³,Mishina Margarita¹,Wang Yuanyuan⁴⁵,Falls Zackary⁶,Samudrala Ram⁶,Pohl Jan⁴,Knight Paul R.²,Sambhara Suryaprakash¹^ORCID

Affiliation:

1. Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. Department of Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA

3. Oak Ridge Institute for Science and Education (ORISE), CDC Fellowship Program, Oak Ridge, Tennessee, USA

4. Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

5. Association of Public Health Laboratories, Silver Spring, Maryland, USA

6. Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA

Abstract

Preventing and controlling influenza virus infection remains a global public health challenge, as it causes seasonal epidemics to unexpected pandemics. These infections are responsible for high morbidity, mortality, and substantial economic impact.

Funder

HHS | NIH | National Heart, Lung, and Blood Institute

HHS | National Institutes of Health

HHS | NIH | U.S. National Library of Medicine

HHS | NIH | National Center for Advancing Translational Sciences

National Institute of Development Administration

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/cmr.00040-22

Reference423 articles.

1. World Health Organization. 2022. Comparison of number of influenza detections by subtype. https://app.powerbi.com/view?r=eyJrIjoiZTIxMzAwMzYtZWE4NC00YTU2LWE3MTUtMTI0OGY1ZjQyMWViIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9. Retrieved 18 February 2022.

2. Centers for Disease Control and Prevention. 2022. Weekly U.S. influenza surveillance report. https://www.cdc.gov/flu/weekly/index.htm. Retrieved 18 February 2022.

3. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

4. Centers for Disease Control and Prevention. 2020. Past seasons estimated influenza disease burden. https://www.cdc.gov/flu/about/burden/past-seasons.html?web=1&wdLOR=cEAB96504-2317-493E-BEF7-B9E799A85D55. Retrieved 18 February 2022.

5. Centers for Disease Control and Prevention. 2021. People at higher risk of flu complications https://www.cdc.gov/flu/highrisk/index.htm. Retrieved 18 February 2022.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profilaxis vacunal para prevenir infecciones respiratorias agudas en el entorno sanitario;Medicina de Familia. SEMERGEN;2024-11

2. Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo;Antiviral Research;2024-10

3. Identification of new inhibitors for the avian H1N1 virus through molecular docking and dynamic simulation approaches;Journal of the Indian Chemical Society;2024-10

4. PEG-SeNPs as therapeutic agents inhibiting apoptosis and inflammation of cells infected with H1N1 influenza A virus;Scientific Reports;2024-09-12

5. HEX17(Neumifil): An intranasal respiratory biotherapeutic with broad-acting antiviral activity;Antiviral Research;2024-08